T-Cell Lymphoma Overview
T-cell lymphoma is a rare and aggressive form of non-Hodgkin lymphoma that arises in the T-lymphocytes of the immune system. The Lymphoma Research Foundation provides an overview of subtypes, symptoms, diagnosis, and treatment options. Read more on lymphoma.org .
Mantle Cell Lymphoma Treatment (Jaypirca)
Jaypirca (pirtobrutinib) is a targeted therapy approved for the treatment of mantle cell lymphoma in patients who have received at least two prior lines of systemic therapy. It works as a non-covalent BTK inhibitor, offering a novel option for relapsed or refractory cases. Learn more at Jaypirca.com .